Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
-
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · Jan 2020
[Provision of healthcare for people with risky alcohol use and severe alcohol use disorders in the state of Bremen, Germany: demand and guideline concordance?]
Early detection of risky alcohol use and severe alcohol use disorders (AUDs) is crucial to avoid adverse health consequences. The German "Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders" recommend to routinely screen patients for hazardous alcohol use and to subsequently conduct brief interventions, for example in primary healthcare. For severe AUDs, provision of withdrawal treatment is recommended in inpatient settings if complications are anticipated. ⋯ In Bremen, provision of guideline-conform healthcare for hazardous alcohol use and severe AUDs is insufficient, especially among 21- to 39-year-olds.
-
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · Nov 2019
Review[Health damages after ingestion of button batteries in childhood].
Exposure of children under 5 years to button batteries may result in severe corrosive injury, especially when they get stuck in the oesophagus. The injury is caused by the discharge current of the batteries. An increasing number of button battery ingestions have been described worldwide. ⋯ Serious complications and even death after button battery ingestion are described in Germany. Button batteries impacted in the oesophagus should be removed emergently to minimize corrosive injury. Because no symptoms or only slight discomfort are developed initially, awareness of button batteries as a unique corrosive hazard among the public and clinicians is an important requirement for prompt diagnosis and treatment resulting in a satisfactory outcome.
-
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · Nov 2019
Review[Carbon monoxide-an underestimated risk? Awareness, perception, knowledge, and prevention activities].
Every year, hospitals in Germany treat roughly 450,000 people in the aftermath of poisoning incidents. To reduce the number of poisoning accidents, it is essential to inform the public about poisoning risks and the possibilities for prevention. ⋯ The results offer first insights into the target groups and possible dissemination paths for future risk communication activities.
-
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · Jul 2019
Review[Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield].
Recent systematic reviews (SRs) came to divergent conclusions on the efficacy and safety of medical marijuana and cannabis-based medicines for chronic pain management. This paper gives an overview and critical appraisal of the methods of recent SRs of randomized controlled trials (RCTs) with cannabis medicines for chronic pain. Selective search of the literature, incorrect data analyses and presentation in favor of cannabis medicines can be detected in both RCTs and SRs. ⋯ Cannabis medicines can be regarded to be third-line therapy for chronic neuropathic pain. There are signals of a lack of efficacy for all other chronic pain syndromes. New high-quality RCTs and approaches, such as network meta-analyses combining different treatments and controlled and observational including additional outcomes than pain relief, are necessary to better define the importance of cannabis medicines for chronic pain management.
-
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz · Jul 2019
Review[Cannabis and cannabinoids in palliative care].
Cannabis and cannabinoids are discussed as a potential treatment for a broad spectrum of diseases and symptoms. This article presents current evidence for the use of cannabis and cannabinoids in palliative care and delivers background information. For this purpose recent literature was examined and evaluated. ⋯ Cannabinoids may be considered as a therapeutic attempt in the treatment of cancer pain and weight gain in patients with HIV as well as other symptoms (such as nausea and loss of appetite) if established treatments fail. Further studies involving more patients are needed to evaluate the therapeutic potential of cannabis and cannabinoids. However, special conditions in the field of palliative care make it difficult to carry out high-quality studies.